Company intelligence / Profile preview

EQT Mid Market Asia III

Amsterdam, Netherlands

Ownership: Private
Development stage: Other

Overview

EQT Mid Market Asia III is a USD 800 million private equity fund closed in 2018, targeting control or co-control investments in mid-market companies (enterprise value USD 30-250 million) in Greater China and Southeast Asia across sectors including Healthcare, Services, Consumer, TMT, and Industrial Technology.

Industry: Investors

Beyond the preview

Go deeper on EQT Mid Market Asia III.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EQT Mid Market Asia III.

Explore the full profile